Language

English

Publication Date

4-1-2025

Journal

JACC: CardioOncology

DOI

10.1016/j.jaccao.2024.11.003

PMID

40246378

PMCID

PMC12046809

PubMedCentral® Posted Date

1-7-2025

PubMedCentral® Full Text Version

Post-print

Abstract

This document serves as a perspective on quality assessments in the discipline of cardio-oncology. We aim to define the current landscape, identify needs for quality and outcome improvements, and propose a roadmap for establishing viable metrics to improve patient care. Specifically, this document: 1) addresses the current lack of measurable high-quality metrics in cardio-oncology and their implications; 2) highlights needs and topic-specific barriers; 3) illustrates the process and application of a measurable quality metric; and 4) provides a framework to demonstrate measurable value for the growing population of patients with cancer and cardiovascular diseases.

Keywords

anthracycline, cancer survivorship, echocardiography, guidelines, Her2 therapy, outcomes, prevention, risk factor

Published Open-Access

yes

ga1 (1).jpg (150 kB)
Graphical Abstract

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.